Literature DB >> 10781089

Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73.

J Goudsmit1, N Renwick, N H Dukers, R A Coutinho, S Heisterkamp, M Bakker, T F Schulz, M Cornelissen, G J Weverling.   

Abstract

We have shown previously that human herpesvirus 8 (HHV8) seroconversion for antibodies to the latency-associated nuclear antigen encoded by ORF73 and/or the lytic capsid antigen (vp19) encoded by ORF65 is associated with orogenital contact and is strongly linked to the development of Kaposi's sarcoma among HIV-infected individuals in the Amsterdam Cohort Studies. Here, we investigate the relationship between seroconversion to these antigens and primary HHV8 infection. Between 1984 and 1997, 215 HHV8 seroconversions to ORF73 (106 cases or 49%) and/or to ORF65 (159 cases or 74%) were recorded in the cohort of homosexual men. The HHV8 seroconversion rate among HIV-infected homosexual men (6.2 per 100 person years) was consistently higher than among HIV-uninfected men (2.6 per 100 person years). In HIV-infected but not in uninfected individuals, seroconversion to ORF73/latency-associated nuclear antigen precedes that to ORF65/vp19. Antibody levels to both ORF65- and ORF73-encoded antigens were higher in HIV-infected than in HIV-uninfected men, and among HIV-seropositives, antibody levels to ORF65/vp19 rise even higher with declining CD4 cell counts and peak with Kaposi's sarcoma development, suggesting continuing and increasing viral replication. In 10.3% of HHV8 seroconversions, transient serum viremia could be demonstrated before or at seroconversion. Together with the previously reported link between unprotected orogenital sex and HHV8 seroconversion, our observations suggest that HHV8 seroconversions result from primary infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781089      PMCID: PMC18319          DOI: 10.1073/pnas.97.9.4838

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  The transmission of infectious mononucleosis.

Authors:  R J HOAGLAND
Journal:  Am J Med Sci       Date:  1955-03       Impact factor: 2.378

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Isolation of equine herpesvirus type 2 from foals, showing respiratory symptoms.

Authors:  V Pálfi; S Belák; T Molnár
Journal:  Zentralbl Veterinarmed B       Date:  1978-03

4.  Oral excretion of Herpesvirus saimiri in captive squirrel monkeys and incidence of infection in feral squirrel monkeys.

Authors:  L A Falk; S Nigida; F Deinhardt; R W Cooper; J I Hernandez-Camacho
Journal:  J Natl Cancer Inst       Date:  1973-12       Impact factor: 13.506

5.  Transmission of equine herpesvirus 2 to the mouse: characterization of a new laboratory infection model.

Authors:  S M Rizvi; J D Slater; A J Slade; H J Field
Journal:  J Gen Virol       Date:  1997-05       Impact factor: 3.891

6.  Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma.

Authors:  T R O'Brien; D Kedes; D Ganem; D R Macrae; P S Rosenberg; J Molden; J J Goedert
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

7.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

8.  Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.

Authors:  M Cornelissen; G Mulder-Kampinga; J Veenstra; F Zorgdrager; C Kuiken; S Hartman; J Dekker; L van der Hoek; C Sol; R Coutinho
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids.

Authors:  J R LaDuca; J L Love; L Z Abbott; S Dube; A E Freidman-Kien; B J Poiesz
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

10.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

Authors:  V Beral; T A Peterman; R L Berkelman; H W Jaffe
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

View more
  15 in total

1.  Human herpesvirus 8 load in matched serum and plasma samples of patients with AIDS-associated Kaposi's sarcoma.

Authors:  Abeltje M Polstra; Remco Van Den Burg; Jaap Goudsmit; Marion Cornelissen
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Pyogenic granuloma: an unrecognized cause of gastrointestinal bleeding.

Authors:  Susanne van Eeden; G Johan A Offerhaus; Folkert H Morsink; Bastiaan P van Rees; Olivier R C Busch; Carel J M van Noesel
Journal:  Virchows Arch       Date:  2004-04-15       Impact factor: 4.064

3.  Comparison of serologic assays for detection of antibodies against human herpesvirus 8.

Authors:  J L Corchero; E C Mar; T J Spira; P E Pellett; N Inoue
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

4.  Antibody responses to lytic and latent human herpesvirus 8 antigens among HIV-infected patients in central China.

Authors:  T J Zhang; N He; Y Y Ding; Q W Jiang; C Wood
Journal:  Biosci Trends       Date:  2012-06       Impact factor: 2.400

Review 5.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

Review 6.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein.

Authors:  Pey-Jium Chang; George Miller
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 8.  Human herpesvirus 8--a novel human pathogen.

Authors:  Daniel C Edelman
Journal:  Virol J       Date:  2005-09-02       Impact factor: 4.099

9.  Lichen planus remission is associated with a decrease of human herpes virus type 7 protein expression in plasmacytoid dendritic cells.

Authors:  Henry J C de Vries; Marcel B M Teunissen; Fokla Zorgdrager; Daisy Picavet; Marion Cornelissen
Journal:  Arch Dermatol Res       Date:  2007-04-03       Impact factor: 3.017

10.  Incidence of human herpesvirus 8 (HHV-8) infection among HIV-uninfected individuals at high risk for sexually transmitted infections.

Authors:  Massimo Giuliani; Paola Cordiali-Fei; Concetta Castilletti; Aldo Di Carlo; Guido Palamara; Stefano Boros; Giovanni Rezza
Journal:  BMC Infect Dis       Date:  2007-12-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.